Jetema Co Ltd banner

Intrinsic Value

The intrinsic value of Jetema Co Ltd (216080) under the Base Case is 7 688.6 KRW per share. Compared with the current market price of 5 990 KRW, the stock appears Undervalued by 22% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
₩7 688.6
Undervaluation 22%
Intrinsic Value
Price ₩5 990
J

Jetema Co Ltd is cheaper than usual. It was this cheap or cheaper on just 12% of days in the past 5 years.

Monitor Jetema Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ₩6 150.88
Get notified when the price drops into your buy zone
Intrinsic Value ₩7 688.6
Margin of Safety 20% ₩6 150.88
Current Price ₩5 990
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to Jetema Co Ltd

Fundamental Analysis

What Jetema Does

Pharmaceuticals Health Care

Jetema Co Ltd is a South Korean medical aesthetics company that develops and sells products used in cosmetic procedures. Its core offerings include injectable fillers, botulinum toxin products, and other device-based treatments that doctors use to smooth wrinkles, restore facial volume, and improve appearance without major surgery. The company works mainly with dermatology clinics, plastic surgery practices, and other medical providers that buy these products for in-office treatments.

Headquarters
Korea KR
Employees
188
IPO date
Nov 14, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Jetema Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Jetema Co Ltd stock?

The intrinsic value for Jetema Co Ltd (216080) under the Base Case is 7 688.6 KRW.

Is Jetema Co Ltd stock undervalued or overvalued?

Compared with the current market price of 5 990 KRW, the stock appears Undervalued by 22% .

Back to Top